{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:14:57Z","timestamp":1778087697420,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humpath.2026.106099","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:55:04Z","timestamp":1772524504000},"page":"106099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical, pathologic, and molecular profiles of sarcomatoid and rhabdoid differentiated clear cell renal cell carcinoma: A series of 21 tumors"],"prefix":"10.1016","volume":"172","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-3340","authenticated-orcid":false,"given":"Huizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106099_bib1","article-title":"The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma","volume":"33","author":"Hahn","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.humpath.2026.106099_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-200404000-00002","article-title":"Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome","volume":"28","author":"Cheville","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/003130299104945","article-title":"Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies","volume":"31","author":"Delahunt","year":"1999","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106099_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000478-200103000-00001","article-title":"Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases","volume":"25","author":"de Peralta-Venturina","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","article-title":"Sarcomatoid renal cell carcinoma: biology, natural history and management","volume":"17","author":"Blum","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2026.106099_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5858\/2007-131-102-RCCWRF","article-title":"Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53","volume":"131","author":"Leroy","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106099_bib7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000478-200010000-00002","article-title":"Renal cell carcinoma with rhabdoid features","volume":"24","author":"Gokden","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib8","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/PAS.0000000000002233","article-title":"Sarcomatoid and rhabdoid renal cell carcinoma: clinical, pathologic, and molecular genetic features","volume":"48","author":"Adeniran","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106099_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eururo.2016.01.051","article-title":"Genomic characterization of renal cell carcinoma with sarcomatoid dedifferentiation pinpoints recurrent genomic alterations","volume":"70","author":"Malouf","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106099_bib11","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106099_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.humpath.2026.106099_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/PAS.0b013e3181cad8c9","article-title":"Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases","volume":"34","author":"Miller","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","article-title":"A clearer view of the molecular complexity of clear cell renal cell carcinoma","volume":"10","author":"Frew","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies","volume":"15","author":"Piva","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.humpath.2026.106099_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106099_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2559.2002.01427.x","article-title":"Renal cell carcinoma with rhabdoid features: an aggressive neoplasm","volume":"41","author":"Kuroiwa","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106099_bib18","doi-asserted-by":"crossref","first-page":"427 e417","DOI":"10.1016\/j.urolonc.2015.04.011","article-title":"Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation","volume":"33","author":"Adibi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2026.106099_bib19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1464-410X.2011.10785.x","article-title":"Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma","volume":"109","author":"Shuch","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2026.106099_bib20","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.humpath.2007.02.002","article-title":"The evolution of collagen expression in sarcomatoid renal cell carcinoma","volume":"38","author":"Delahunt","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/his.13447","article-title":"Low-grade spindle cell proliferation in clear cell renal cell carcinoma is unlikely to be an initial step in sarcomatoid differentiation","volume":"72","author":"Tanas Isikci","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106099_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neo.2018.12.006","article-title":"Expression and mutation patterns of PBRM1, BAP1 and SETD2 mirror specific evolutionary subtypes in clear cell renal cell carcinoma","volume":"21","author":"Bihr","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2026.106099_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/10668969231157317","article-title":"Exploration of morphological features of clear cell renal cell carcinoma with PBRM1, SETD2, BAP1, or KDM5C mutations","volume":"31","author":"Liu","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106099_bib24","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.7150\/jca.27281","article-title":"Comprehensive analysis of BAP1 somatic mutation in clear cell renal cell carcinoma to explore potential mechanisms in silico","volume":"9","author":"Jin","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2026.106099_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41467-021-21068-9","article-title":"Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma","volume":"12","author":"Bakouny","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2026.106099_bib26","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/cncr.22677","article-title":"Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy","volume":"109","author":"Pantuck","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106099_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106099_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41598-020-57534-5","article-title":"Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers","volume":"10","author":"Malouf","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2026.106099_bib29","article-title":"Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients","volume":"40","author":"Kiatprungvech","year":"2024","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.humpath.2026.106099_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102091","article-title":"BAP1: not just a BRCA1-associated protein","volume":"90","author":"Louie","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.humpath.2026.106099_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1389450114666140106101412","article-title":"Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities","volume":"15","author":"Hong","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.humpath.2026.106099_bib32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/2326-6066.CIR-15-0150","article-title":"PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation","volume":"3","author":"Joseph","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:54:19Z","timestamp":1778086459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"alternative-id":["S0046817726000687"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106099","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, pathologic, and molecular profiles of sarcomatoid and rhabdoid differentiated clear cell renal cell carcinoma: A series of 21 tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106099"}}